Browse by Medical Category
Accepting New Patients
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Winkelman received his PhD in Psychobiology from Harvard University, an MD from Harvard Medical School and then completed both a residency in Psychiatry and a fellowship in Sleep Medicine at Massachusetts General Hospital. He was Medical Director of the Sleep Program at McLean Hospital and subsequently Medical Director of the sleep laboratory at Brigham and Women's Hospital.
He is currently a Professor of Psychiatry at Harvard Medical School and chief of the Sleep Disorders Clinical Research Program in the Department of Psychiatry at Massachusetts General Hospital.
Dr. Winkelman's research has primarily focused in two areas: 1) epidemiology, physiology, cardiovascular consequences and treatment of restless legs syndrome, and 2) neurobiology and treatment of insomnia. He has lectured in and directed post-graduate medical education courses in sleep disorders nationally and internationally. Dr. Winkelman serves on the editorial boards of Sleep Medicine and CNS Drugs. He has published more than 150 articles, reviews and book chapters and is also the editor of the textbook Foundations of Psychiatric Sleep Medicine, Cambridge University Press (2011).
View my most recent publications at PubMed
A year-long study has found that pregabalin – FDA-approved to treat nerve pain and seizures – was effective in reducing symptoms of restless leg syndrome and, with long-term treatment, was less likely than pramipexole – which activates the dopamine neurotransmission system and is FDA approved for RLS treatment – to cause worsening of symptoms.
Back to Top